Technical Analysis for CGC - Canopy Growth Corporation
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | -1.83% | |
NR7 | Range Contraction | -1.83% | |
Narrow Range Bar | Range Contraction | -1.83% | |
Inside Day | Range Contraction | -1.83% | |
Wide Bands | Range Expansion | -1.83% | |
Oversold Stochastic | Weakness | -1.83% | |
Bullish Engulfing | Bullish | -0.79% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 17 hours ago |
Fell Below Previous Day's Low | about 17 hours ago |
Possible NR7 | about 17 hours ago |
Possible Inside Day | about 17 hours ago |
Down 1% | about 22 hours ago |
Get a Trading Sidekick!
- Earnings date: 11/08/2024
Canopy Growth Corporation Description
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eight cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Alcohol Cannabis Genetics Clinical Research Medicinal Plants Herbalism Medical Cannabis Hemp Cannabis In Canada Healthcare Practitioners Shareholder Value Softgel
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 14.92 |
52 Week Low | 2.755 |
Average Volume | 5,595,833 |
200-Day Moving Average | 6.20 |
50-Day Moving Average | 4.50 |
20-Day Moving Average | 4.52 |
10-Day Moving Average | 3.96 |
Average True Range | 0.38 |
RSI (14) | 37.89 |
ADX | 17.38 |
+DI | 20.06 |
-DI | 26.83 |
Chandelier Exit (Long, 3 ATRs) | 4.65 |
Chandelier Exit (Short, 3 ATRs) | 4.78 |
Upper Bollinger Bands | 5.83 |
Lower Bollinger Band | 3.22 |
Percent B (%b) | 0.21 |
BandWidth | 57.70 |
MACD Line | -0.27 |
MACD Signal Line | -0.17 |
MACD Histogram | -0.0956 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.91 | ||||
Resistance 3 (R3) | 3.92 | 3.89 | 3.89 | ||
Resistance 2 (R2) | 3.89 | 3.85 | 3.88 | 3.88 | |
Resistance 1 (R1) | 3.82 | 3.82 | 3.81 | 3.81 | 3.87 |
Pivot Point | 3.79 | 3.79 | 3.78 | 3.78 | 3.79 |
Support 1 (S1) | 3.72 | 3.75 | 3.71 | 3.71 | 3.65 |
Support 2 (S2) | 3.69 | 3.72 | 3.68 | 3.64 | |
Support 3 (S3) | 3.62 | 3.69 | 3.64 | ||
Support 4 (S4) | 3.61 |